Central aortic pressure: the link with markers of inflammation and fibrosis and diastolic function parameters in patients with heart failure and preserved ejection fraction

25 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Anastasia Kaburova

National Research Center for Preventive Medicine, Moscow (Russian Federation)

19 More presentations in this session

Presentation thumbnail

Exercise unmasks greater arterial stiffness and arterial load in HFpEF patients vs hypertensive controls

Doctor L. Panah (Boston, US)

Presentation thumbnail

Latent class analysis of echocardiographic phenotypes predicts adverse outcomes and treatment response in heart failure with preserved ejection fraction

Associate Professor D. Kao (Aurora, US)

Presentation thumbnail

The usefulness of handgrip exercise echocardiographic tests for diagnosis of heart failure with preserved ejection fraction compared to invasive bicycle exercise cath

Associate Professor S. Hwang (Incheon, KR)

Presentation thumbnail

Characteristics of Worsening Ejection Fraction during Follow-up in Heart Failure Patients with Preserved Ejection Fraction

Presentation thumbnail

Impact of the geriatric nutritional risk index in non-diabetic patients aged >80 years with heart failure with preserved ejection fraction

Professor Y. Mitsuke (Awara, JP)

Access the full session

Session thumbnail

Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Heart Failure 2019

25 May - 28 May 2019

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources